Terlipressin

Terlipressin acetate is a Vasotocin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective Vasotocin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding.

Terlipressin acetate is a Vasotocin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective Vasotocin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding.

Terlipressin acetate is a Vasotocin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective Vasotocin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding.

Terlipressin acetate is a Vasotocin analogue with potent vasoactive properties. Terlipressin acetate is a highly selective Vasotocin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding.

Biochem/physiol Actions Terlipressin is a synthetic vasopressin analog and agonist. It has been used as a vasoactive drug for treatment of Hepatorenal syndrome in cirrhosis of the liver.

Biochem/physiol Actions Terlipressin is a synthetic vasopressin analog and agonist. It has been used as a vasoactive drug for treatment of Hepatorenal syndrome in cirrhosis of the liver.

General description This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the